Changes in vasoactive factors associated with altered vessel morphology in the tibial metaphysis during ovariectomy-induced bone loss in rats

Bone

Volumn 32, Issue 6, 2003, Pages 630-641

  Mekraldi, S ^a   Lafage Proust, M H ^a   Bloomfield, S ^b   Alexandre, C ^a   Vico, L ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Estrogen; FGF 2; Histomorphometry; Intramedullary vessel; NO synthases; PTHrP; PTHrP receptor; VEGF

Indexed keywords

ESTRADIOL; FIBROBLAST GROWTH FACTOR 2; INDIAN INK; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; EVALUATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PROTEIN EXPRESSION; RAT; TIBIA;

EID: 0142061481     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00099-1     Document Type: Article

References (60)

1. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:1991;175-192.
2. Compston J.E. Sex steroids and bone. Physiol Rev. 81:2001;419-444.
3. Turner R.T., Riggs B.L., Sperlsberg T.C. Skeletal effects of estrogen. Endoc Rev. 15:1994;275-300.
4. Wronski T.J., Cintron M., Doherty A.L., Dann L.M. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology. 123:1988;681-686.
5. Losordo D.W., Isner J.M. Estrogen and angiogenesis a review . Arterioscler Thromb Vasc Biol. 21:2001;6-12.
6. Dai-Do D., Espinosa E., Liu G., Rabelink T.J., Julmy F., Yang Z., Mahler F., Luscher T.F. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells similar effects in cells from postmenopausal females and in males . Cardiovasc Res. 32:1996;980-985.
7. Vogt M.T., Cauley J.A., Kuller L.H., Nevitt M.C. Bone mineral density and blood flow to the lower extremities the study of osteoporotic fractures . J Bone Miner Res. 12:1997;283-289.
8. Cutting C., McCarthy J. Comparison of residual osseous mass between vascularized and nonvascularized onlay bone transfers. Plast Reconstr Surg. 72:1983;672-675.
9. Cruess R.L. Osteonecrosis of bone. Current concepts as to etiology and pathogenesis. Clin Orthop. 208:1986;30-39.
10. Ham A.W. Some histophysiological problems peculiar to calcified tissues. J Bone Joint Surg. 34A:1952;701-728.
11. Marotti G., Zallone A.Z. Changes in the vascular network during the formation of Haversian systems. Acta Anat. 06:1980;84-100.
12. Parfitt A.M. Mechanism of coupling a role for the vasculature . Bone. 26:2000;319-323.
13. Barou O., Mekraldi S., Vico L., Boivin G., Alexandre C., Lafage-Proust M.H. Relationships between trabecular bone remodeling and bone vascularization a quantitative study . Bone. 30:2002;604-612.
14. Chikazu D., Katagiri M., Ogasawara T., Ogata N., Shimoaka T., Takato T., Nakamura K., Kawaguchi H. Regulation of osteoclast differentiation by fibroblast growth factor 2 stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors . J Bone Miner Res. 16:2001;2074-2081.
15. Laroche M., Barbier A., Ludot I., Vernhet C., Thiechart M., Viguier G., Mazieres B. Effect of ovariectomy on intraosseous vascularization and bone remodelling in rats action of tiludronate . Osteoporos Int. 6:1996;127-129.
16. Hansen V.B., Forman A., Lundgaard A., Aalkjaer C., Skajaa K., Hansen E.S. Effects of oophorectomy on functional properties of resistance arteries isolated from the cancellous bone of the rabbit femur. J Orthop Res. 19:2001;391-397.
17. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 141:2000;1667-1674.
18. Chikazu D., Hakeda Y., Ogata N., Nemoto K., Itabashi A., Takato T., Kumegawa M., Nakamura K., Kawaguchi H. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem. 275:2000;31444-31450.
19. Liang H., Pun S., Wronski T.J. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology. 140:1999;5780-5788.
20. Hyder S.M., Huang J.C., Nawaz Z., Boettger-Tong H., Makela S., Chiappetta C., Stance l G.M. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect. 108:(Suppl 5):2000;785-790.
21. Reynolds L.P., Kirsch J.D., Kraft K.C., Redmer D.A. Time-course of the uterine response to estradiol-17beta in ovariectomized ewes expression of angiogenic factors . Biol Reprod. 59:1998;613-620.
22. Galbiati M., Magnaghi V., Martini L., Melcangi R.C. Hypothalamic transforming growth factor beta1 and basic fibroblast growth factor mRNA expression is modified during the rat oestrous cycle. J Neuroendocrinol. 13:2001;483-489.
23. Thompson L.P., Weiner C.P. Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619. Circulation. 95:1997;709-714.
24. MacRitchie A.N., Jun S.S., Chen Z., German Z. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res. 81:1997;355-362.
25. Binko J., Murphy T.V., Majewski H. 17 beta-oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta. Clin Exp Pharmacol Physiol. 25:1998;120-127.
26. Wimalawansa S.J., De Marco G., Gangula P., Yallampalli C. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone. 8:1996;301-304.
27. Armour K.J., van't Hof R.J., Armour K.E., Torbergsen A.C., Del Soldato P., Ralston S.H. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026). Arthritis Rheum. 44:2001;2185-2192.
28. Casey M.L., Mibe M., MacDonald P.C. Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J Clin Endocrinol Metab. 77:1993;188-194.
29. Thiede M.A., Harmn S.C., Hasson D.M., Gardner R.M. In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17 beta-estradiol. Endocrinology. 128:1991;2317-2323.
30. Paspaliaris V., Petersen D.N., Thiede M.A. Steroid regulation of parathyroid hormone-related protein expression and action in the rat uterus. J Steroid Biochem Mol Biol. 53:1995;259-265.
31. Shirley B. Partial synchrony of the oestrous cycles of rats introduced to a new environment. J Endocrinol. 77:1978;195-202.
32. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
33. Lee S.K., Lorenzo J.A. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures correlation with osteoclast-like cell formation . Endocrinology. 140:1999;3552-3561.
34. el-Husseini A.el-D., Paterson J.A., Shiu R.P. Basic fibroblast growth factor (bFGF) and two of its receptors, FGFR1 and FGFR2 gene expression in the rat brain during postnatal development as determined by quantitative RT-PCR . Mol Cell Endocrinol. 104:1994;191-200.
35. Ni Y., May V.V., Braas K., Osol G. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol. 273:1997;H938-944. (2 Pt 2).
36. Wu F., Park F., Cowley A.W. Jr, Mattson D.L. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol. 276(6 Pt 2):1999;F874-881.
37. Riancho J.A., Salas E., Zarrabeitia M.T., Olmos J.M., Amado J.A., Fernandez-Luna J.L., Gonzalez-Macias J. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res. 10:1995;439-446.
38. Guenther H.L., Hofstetter W., Moseley J.M., Gillespie M.T., Suda N., Martin T.J. Evidence for the synthesis of parathyroid hormone-related protein (PTHrP) by nontransformed clonal rat osteoblastic cells in vitro. Bone. 16:1995;341-347.
39. Cros M., Silve C., Graulet A.M., Morieux C., Urena P., de Vernejoul M.C., Bouizar Z. Estrogen stimulates PTHrP but not PTH/PTHrP receptor gene expression in the kidney of ovariectomized rat. J Cell Biochem. 70:1998;84-93.
40. Dukas K., Sarfati P., Vaysse N., Pradayrol L. Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Anal Biochem. 215:1993;66-72.
41. Shibayama Y., Nishimoto M., Nakata K. Microvascular events in bone marrow related to development of and recovery from bone atrophy in thiotepa-treated rats. Exp Toxicol Pathol. 45:1993;129-133.
42. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry standardization of nomenclature, symbols and units . J Bone Miner Res. 2:1987;595-610.
43. Mustalahti K., Collin P., Sievanen H., Salmi J., Maki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet. 354:1999;744-745.
44. Ferrara N., Houck K.A., Jakeman L.B., Winer J., Leung D.W. The vascular endothelial growth factor family of polypeptides. J Cell Biochem. 47:1991;211-218.
45. Pun S., Dearden R.L., Ratkus A.M., Liang H., Wronski T.J. Decreased bone anabolic effect of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone. 28:2001;220-226.
46. Zachary I., Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 49:2001;568-581.
47. Bausero P., Ben-Mahdi M., Mazucatelli J., Bloy C., Perrot-Applanat M. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol Heart Circ Physiol. 279:2000;H2033-2042.
48. Perrot-Applanat M., Ancelin M., Buteau-Lozano H., Meduri G., Bausero P. Ovarian steroids in endometrial angiogenesis. Steroids. 65:2000;599-603.
49. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Spector J.A., Greenwald J.A., Chin G.S., Ueno H., Gittes G.K., Longaker M.T. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology. 141:2000;2075-2083.
50. van't Hof R.J., Ralston S.H. Nitric oxide and bone. Immunology. 103:2001;255-261.
51. Dulak J., Jozkowicz A., Dembinska-Kiec A., Guevara I., Zdzienicka A., Zmudzinska-Grochot D., Florek I., Wojtowicz A., Szuba A., Cooke J.P. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:2000;659-666.
52. Armour K.E., Ralston S.H. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology. 139:1998;799-802.
53. Wimalawansa S.J. Restoration of ovariectomy-induced osteopenia by nitroglycerin. Calcif Tissue Int. 66:2000;56-60.
54. Armour K.E., Armour K.J., Gallagher M.E., Godecke A., Helfrich M.H., Reid D.M., Ralston S.H. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology. 142:2001;760-766.
55. van't Hof R.J., Armour K.J., Smith L.M., Armour K.E., Wei X.Q., Liew F.Y., Ralston S.H. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. Proc Natl Acad Sci USA. 97:2000;7993-7998.
56. Kanatani M., Sugimoto T., Takahashi Y., Kaji H., Kitazawa R., Chihara K. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation. J Bone Miner Res. 13:1998;854-862.
57. Kaji H., Sugimoto T., Kanatani M., Nasu M., Chihara K. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway. Endocrinology. 137:1998;2217-2224.
58. Esbrit P., Alvarez-Arroyo M.V., De Miguel F., Martin O., Martinez M.E., Caramelo C. C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol. 11:2000;1085-1092.
59. Egrise D., Martin D., Neve P., Vienne A., Verhas M., Schoutens A. Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats. Calcif Tissue Int. 50:1992;336-341.
60. Kapitola J., Kubickova J., Andrle J. Blood flow and mineral content of the tibia of female and male rats changes following castration and/or administration of estradiol or testosterone . Bone. 16:1995;69-72.